HomeCompareGDNSF vs MRK

GDNSF vs MRK: Dividend Comparison 2026

GDNSF yields 442.28% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GDNSF wins by $24101.25M in total portfolio value
10 years
GDNSF
GDNSF
● Live price
442.28%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24101.31M
Annual income
$16,681,728,227.97
Full GDNSF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GDNSF vs MRK

📍 GDNSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGDNSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GDNSF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GDNSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GDNSF
Annual income on $10K today (after 15% tax)
$37,593.98/yr
After 10yr DRIP, annual income (after tax)
$14,179,468,993.77/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GDNSF beats the other by $14,179,460,665.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GDNSF + MRK for your $10,000?

GDNSF: 50%MRK: 50%
100% MRK50/50100% GDNSF
Portfolio after 10yr
$12050.68M
Annual income
$8,340,869,013.06/yr
Blended yield
69.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GDNSF
Analyst Ratings
2
Hold
Consensus: Hold
Price Target
$0.45
-0.5% upside vs current
Range: $0.45 — $0.45
Altman Z
-0.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GDNSF buys
0
MRK buys
0
No recent congressional trades found for GDNSF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGDNSFMRK
Forward yield442.28%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$24101.31M$56.8K
Annual income after 10y$16,681,728,227.97$9,798.13
Total dividends collected$23436.57M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$0.45$128.54

Year-by-year: GDNSF vs MRK ($10,000, DRIP)

YearGDNSF PortfolioGDNSF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$54,928$44,228.22$11,206$366.19+$43.7KGDNSF
2$285,818$227,044.59$12,650$502.35+$273.2KGDNSF
3$1,409,957$1,104,132.35$14,407$694.19+$1.40MGDNSF
4$6,599,080$5,090,425.56$16,585$967.82+$6.58MGDNSF
5$29,327,298$22,266,282.64$19,342$1,363.89+$29.31MGDNSF
6$123,861,228$92,481,018.56$22,913$1,947.19+$123.84MGDNSF
7$497,564,534$365,033,020.19$27,662$2,823.89+$497.54MGDNSF
8$1,902,841,574$1,370,447,523.09$34,159$4,173.35+$1902.81MGDNSF
9$6,934,187,856$4,898,147,371.68$43,337$6,308.80+$6934.14MGDNSF
10$24,101,309,234$16,681,728,227.97$56,776$9,798.13+$24101.25MGDNSF

GDNSF vs MRK: Complete Analysis 2026

GDNSFStock

Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.

Full GDNSF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GDNSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GDNSF vs SCHDGDNSF vs JEPIGDNSF vs OGDNSF vs KOGDNSF vs MAINGDNSF vs JNJGDNSF vs ABBVGDNSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.